Vets4Ukraine2022 is the brainchild of a group of twenty veterinary Specialists who are raising money by offering their knowledge and expertise in the form of free CPD delivered online, via Facebook and Linkedin.
So far, they've raised £2,236 for the British Red Cross.
For details of this group's activities and the free CPD it is offering colleagues, visit https://www.facebook.com/groups/1491854917875566/permalink/1497308427330215/
Meanwhile the FECAVA and The Webinar Vet are running the Vets for Ukraine Online Conference, a CPD event online on the 9th April from 10:00am to 10:00pm.
More details of that initiative, which is raising money for the Disasters Emergency Committee and Four Paws can be found here: https://www.thewebinarvet.com/pages/ukraine-veterinary-aid-conference/
Last but not least, British Veterinary Professionals for Ukraine is working to get essential medical supplies - both for animals and humans - delivered to Ukraine.
BVP4U is asking for supplies to be sent to BVP4UA c/o Hoermann Equine,Wrights Lodge East, Oakham Road, Whissendine, Rutland, LE15 7HA.
A list of specific requirements is available on the BVP4UA facebook page https://www.facebook.com/groups/britishvetsforukraine.
Alternatively, veterinary practices can buy supplies through their regular wholesalers (MWI/Covetrus/NVS) and have them delivered direct to BVP4UA by emailing their wholesaler with details of what they want to donate.
Other companies who do not operate through wholesalers may also be prepared to deliver direct.
Cash donations can be made via gofundme> to allow direct purchasing of the most needed veterinary supplies https://gofund.me/f7f25366.
BCF Technology has launched a competition in which the person who submits the best photograph with the theme of: All in a day's work - animal imaging, will win an iPad 2.
To enter the competition, you need to post your photographs, (and tell BCF a little about the story behind the images) at www.facebook.com/bcftechnology or email them to: info@bcftechnology.com
Jason Rogers, Marketing Manager at BCF said: "We wanted to create a fun way to show just how interesting and different each days work is when imaging animals. We have made the competition open to all that work with animal imaging including our staff, dealers and vets, vet nurses, animal contractors, etc from all over the world.
"It is great to see the BCF office in the States and our international dealers also promoting the competition in their own countries, making the competition truly international. Response to the competition has been fantastic - see our facebook page to some entries for yourself."
The closing date for the competition is 30th September 2011.
For more information, visit: www.bcftechnology.com
Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.
The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.2
According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence. Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.5 This quality of evidence is, says Hill's, in contrast to many supplements.
John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."
Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis1, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.
Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.
Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk or http://www.hillspetmobility.ie/
References
Vétoquinol, manufacturer of Epiphen (phenobarbital), for the control of epilepsy in dogs, has announced the launch of a new starter pack for clients that are embarking on treatment.
The starter packs contain a variety of support materials designed to help owners better understand the condition and its treatment. They sit alongside other support given by the company, which includes an 'Ask the Expert' helpline through which Epiphen veterinary customers can speak to a neurology specialist at The Animal Health Trust in Newmarket, where Vetoquinol sponsors a neurology clinician.
Abbie King, Product Manager for Epiphen, said: ''Our 'Ask the Expert' helpline is a successful service that has been running for several years. 30% of the calls to Vetoquinol's technical team relate to this challenging condition meaning there are few queries our technical team have not tackled before. If extra help is necessary we have an excellent working relationship with The Animal Health Trust and regularly refer cases to them for further advice. We are very proud of this service and are delighted to be able to continue to provide this helpline for our Epiphen clients.''
To use the 'Ask the Expert' service, or order the support materials, ring 0800 1698197. Alternatively visit: www.vetoquinol.co.uk or www.epiphenonline.co.uk.
The theme of Congress has been chosen to reflect the increasing importance of OVs in safeguarding the UK’s international trade and in protecting human health through disease surveillance and control.
Keynote speakers at this year’s event, which is organised association with the Animal and Plant Health Agency (APHA), include Professor Nigel Gibbens CBE, the UK’s Chief Veterinary Officer; Dr Ryan Waters from The Pirbright Institute in Surrey and Dr Ian Wright, Head of ESCCAP UK & Guideline Director for ESCCAP Europe. It takes place at Alexandra House in Swindon on 21-22 September 2017.
Professor Gibbens said: "UK vets play a range of critical roles, protecting our country from endemic and exotic diseases, leading the frontline response to global challenges, such as antibiotic resistance, and safeguarding our animals to ensure our welfare standards remain the best in the world.
"I look forward to joining our OVs to celebrate this essential work and to explore the themes of this year’s conference - disease control and surveillance - which recognise the importance of vets to international trade and their contribution to our thriving food and farming industry."
David Babington MRCVS, Managing Director of Improve International, added: "This year’s OV Conference will, as usual, feature dedicated lecture streams aimed at large animal, small animal and equine practitioners. We hope the new workshops on the more specialist Official Controls Qualifications (Veterinarian), including those relating to the export of poultry (OCQ(V) AX); the export of food and animal by-products (OCQ(V) PX) and the export of germinal products (OCQ(V) GX), will prove a useful addition to our delegates."
For more information on the Official Veterinarian Conference and Exhibition or to register visit: www.officialvet.com
Veterinary practices are being encouraged to enter the annual Veterinary Marketing Association's (VMA) awards, which now include a practice-only category.
The annual VMA awards are intended to recognise excellence in all aspects of veterinary and animal health marketing. The Practice Marketing Award, sponsored by Pfizer, is awarded to the companion or production animal practice that demonstrates the most initiative and innovation in the marketing of its products and/or services to end users. This can involve the use of any form of activity, including advertising, websites, direct mail and media relations.
Last year's winner of this award was Kessock Equine Vets from Aberdeen, who travelled down to London to receive their award at a presentation lunch. The 2009 awards presentation ceremony takes place on Friday, 19th March at the Old Brewery in Chiswell Street, London. The meeting also presents a very good opportunity for vets to meet representatives from all the major animal health companies.
Tickets for the event cost £115+VAT for VMA/VMPA members (£150+VAT for non-members). The price includes a three-course meal (prepared by a two-star Michelin chef) with wine, a champagne reception and entertainment by a top comedian.
Further information on the awards is available on the Veterinary Marketing Association's website - http://www.vma.org.uk/. Closing date for entries is 5th February 2010.
Richard Hepburn MRCVS has launched what is thought to be the world's first equine gastric ulcer study, designed to improve understanding and knowledge of ulceration in performance horses.
Mr Hepburn is conducting the InnerVision study of performance horses, which is being championed by the University of Liverpool, as part of his PhD.
21 appointed practices across the UK are participating in the study, and with each practice scoping between 10 and 20 animals, it will include well over 200 performance horses. Mr Hepburn said: "Gastric ulceration in sports horses is poorly understood, especially compared with racehorses. But what we do know is that it's a very important factor in the performance and well-being of many horses in training and competition."
2012 Paralympic Gold medallist Deb Criddle MBE also attended the launch event. She explained the difference that regular gastroscopy and ulcer management of Paralympic team horses had made to her success. Speaking about her Beijing ride, Pavaroti, she said: "If it weren't for the diagnosis and treatment of Pavaroti's ulcers I don't know what we'd have done. I would probably have had to withdraw him from training, so it made the difference between our partnership continuing or not".
Mr Hepburn expects a prevalence of approximately 60% and, keen to increase understanding of glandular ulceration, participants are being tasked to scope all areas of the stomach, pylorus and duodenum to ensure that every incidence of ulceration is diagnosed and recorded.
He says he is particularly eager to find out more about glandular disease, which hitherto has had little research: "Glandular disease appears to have a very different aetiology to squamous ulceration, and often presents with different signs. We also believe that prevalence of glandular ulceration is most common in sports horses."
"We hope that publication of this study will help all equine vets in their work with performance horses and the quest to prevent and manage equine ulcers," he added.
Merial is supporting the study with management assistance.
The BVA has expressed its disappointment at a report instructed by the Welsh Government that recommends CCTV should not be mandatory in slaughterhouses in Wales.
The Safeguarding Animal Welfare at Slaughter Task and Finish Group’s report, which outlines the findings of the Group’s investigation into the welfare of animals in slaughterhouses and the potential role of CCTV, concluded that there was not a "sufficient basis" for making CCTV in Welsh abattoirs mandatory.
The BVA and the Veterinary Public Health Association (VPHA) believe mandatory CCTV in slaughterhouses and veterinary surgeons' unrestricted access to CCTV footage are vital in order to safeguard animal welfare, assist with enforcement and instil customer confidence.
Dr Neil Paton, BVA Welsh Branch President, said: "We are disappointed that the Task and Finish Group has not taken on board the concerns of vets working in slaughterhouses and not followed the logic of their own arguments about the benefits of CCTV highlighted in the report. While we know that CCTV is not the answer to all welfare concerns, it is recognised as an important tool by the Farm Animal Welfare Committee and encourages the highest standards of animal welfare and good stockmanship. We also need to ensure that where CCTV is installed, vets can have access to the footage. If there isn’t CCTV footage, or vets cannot access the footage, how can the number of reported incidents in abattoirs be verified?"
The report, The Need for and Possible Implementation of a Workable System of CCTV in All Slaughterhouses in Wales, details that only eight large abattoirs of the total 26 abattoirs in Wales have CCTV. Although the bulk of animals in Wales are slaughtered in these eight abattoirs, lack of CCTV in other abattoirs means 3.4% of poultry are slaughtered without CCTV safeguards, accounting for over 2 million birds, and 10.5% of sheep, pigs and cattle are slaughtered in abattoirs without CCTV – nearly 385,000 animals. The potential risk of welfare harm to these animals is increased by this lack of CCTV.
Gudrun Ravetz, President of the British Veterinary Association said: "What vets who work in slaughterhouses, and all those who care about animal welfare, are striving for is a culture of compassion in abattoirs. CCTV is an important tool in encouraging and implementing such a culture. The report’s recommendations encourage abattoirs to install and use CCTV effectively for training purposes, but, together with the VPHA, we would like to re-emphasise our calls for CCTV to be mandatory in all slaughterhouses in the UK and for legislation to ensure that footage is readily available to vets. We recognise that the cost of installing CCTV may be a burden for some very small abattoirs, but it is important that the animals we farm for food have both a good life and a humane death and CCTV has a key role to play in ensuring these requirements are met."
The report also outlined a number of other recommendations, which are welcomed by BVA, including the request for grants to be made available to assist small sites invest in the equipment and an additional focus on the improvement of welfare of animals during transport to slaughter.
The BSAVA has released the final figures showing that 6,331 veterinary surgeons, nurses, practice managers and students attended the event, up from 6,178 in 2013.
Outgoing BSAVA President Professor Michael Day was delighted that so many attended. He said: "What continues to set BSAVA Congress apart is simply 'quality'. The quality of the faultless organisation, the quality of the scientific content, and the quality of our exhibition and incomparable social programme."
A few other numbers from Congress this year included:
Sunday saw the inauguration of the new BSAVA President Katie McConnell. She said: "Like so many previous presidents, I look back on my early volunteering days with deep affection but it would have been a great surprise to my earlier self to be told that one day I would be the BSAVA President.
"During my presidential year I would like to meet as many BSAVA members as I can, hopefully in their own regions. I plan to travel to regional BSAVA continuing education meetings, not to stand up and lecture but to listen to individual members and find out what the BSAVA means to them. The BSAVA is run by members for members and the only way to shape its work is to become engaged with it."
John Alborough presented the awards at the event. Liz Rawlings from Dechra said: "It was certainly a whirlwind at this year’s LVS and we are delighted to have scooped such a prestigious award." Zoe Appleyard-Ley, Co-Founder and Managing Director at Rockster Superfood for Dogs said: "We were so excited by the response Rockster had at the London Vet Show, and thrilled to have been given the award by VetSurgeon.org."
The traditional approach is to use anatomical knowledge to inject pain relief in the area of the nerves to be blocked.
Liz is leading a move away from this approach to a more precise method which uses ultrasound guidance to visualise the nerves, allowing the local anaesthetic to be placed directly around the nerve itself.
For some nerve blocks, it is possible to block just the sensory branches of nerves, which means pets can walk better immediately after surgery while not feeling any pain.
Liz, a past president of the Association of Veterinary Anaesthetists, said: “Local analgesia is now at the forefront of our post-operative care and reliably improves the quality of a pet’s recovery and reduces the need for opioid pain relief, which can cause side effects.
“We’re using the latest techniques to deliver the nerve-blocking anaesthetics to exactly where they’re needed.
“For many of the nerve blocks, the use of ultrasound guidance allows more precise delivery and a complete blockade of the sensory nerves, which is why, here at Paragon, we’ve invested in state-of-the art ultrasound machine designed specifically for superficial and deep nerve blocks.
“This means we can provide more effective immediate post-operative analgesia for our patients and minimise the need for further pain killers.
“The nerves can be directly visualised and local anaesthetic directly placed around the nerve bundles.”
Liz is keen to highlight the advantages of the increased use of local anaesthesia in the treatment of animals. She added: “We’re hoping we’ll soon be able to publish some clinical research on the use of some of the blocking techniques used to demonstrate our clinical impression of their effectiveness in patient management.”
A research project funded by The Horse Trust has made important discoveries about how two peptides regulate the inflammatory response in horses. This knowledge could help with the development of improved anti-inflammatory drugs, which are used to treat a wide range of conditions in horses.
The research project was led by Professor Fiona Cunningham at the Royal Veterinary College in Hertfordshire and Dr Karen Rickards at the Donkey Sanctuary in Sidmouth, assisted by Dr Andrew Brooks at the RVC, and by Dr Kirstie Pickles, now at the Royal (Dick) School of Veterinary Studies in Edinburgh.
Inflammation is associated with a wide range of equine diseases, including recurrent airway obstruction, laminitis and sweet itch. Anti-inflammatory drugs, such as glucocorticosteroids, mainly work by blocking the formation and/or actions of compounds produced in the horse's body that cause inflammatory responses. However, these drugs are not always effective and can have unwanted side effects.
This research, funded by The Horse Trust, aimed to find out more about two naturally-occurring peptides - chains of amino acids that are shorter than proteins - known as annexin-1 and CXCL8. Both have been shown to affect the inflammatory response but little research has been done on their effects in horses. In the long term, knowing more about these compounds could help in the development of new anti-inflammatory drugs with fewer side effects.
During inflammation, neutrophils (a type of white blood cell) stick to the cells lining blood vessels and migrate into inflamed tissue, where they ingest and break down harmful agents. Using techniques that mimic these events, CXCL8 was found to cause adherence and migration of horse neutrophils. However, when it was used in combination with another pro-inflammatory substance, neutrophil migration and adherence were markedly decreased. This suggests that attempts to reduce inflammation by blocking the actions of CXCL8 might not be as beneficial as had been thought.
At the start of the project, the researchers had no information about horse annexin-1, other than its gene sequence, so their first step was to develop a method to detect the peptide in white blood cells. They established that it was present and, as horse annexin-1 has not yet been synthesised, they used a synthetic peptide derived from annexin-1, Ac2-26, to look at the effects on horse neutrophils.
They found that Ac2-26 decreased neutrophil adherence and migration in response to other pro-inflammatory compounds, although at high concentrations the peptide itself caused some cell activation, thereby increasing inflammation. They also found that dexamethasone (a glucocorticosteroid) increased the levels of annexin-1 in cells, indicating that, as in humans, this class of drugs is likely to act in part through the formation of annexin-1.
These findings suggest that the use of compounds which mimic the actions of annexin-1 may have limitations as anti-inflammatory drugs. As glucocorticosteroids partly work by forming annexin-1, further research is needed in order to find out how annexin-1 will act in the horse's body and establish how its formation contributes to the beneficial effects of these drugs.
Professor Cunningham said: "This Horse Trust-funded research has resulted in some very interesting findings about how inflammatory cells are regulated in horses. The receptors that annexin-1 and CXCL8 act upon could be targets for new equine inflammatory drugs, but more research is needed first to fully understand their actions and how they produce these effects."
The team's research has been accepted for publication by the journal Veterinary Immunology & Immunopathology.
Companion Care Vets has announced that it will open its 100th surgery in Llantrisant, South Wales on 7th September 2012.
The surgery will reside within the Pets at Home store in Llantrisant and will be owned and managed by Joint Venture Partner Rhian Bullock who has returned home to Llantristant after working and studying for many years in the USA.
Jane Balmain, Managing Director, Companion Care Vets said: "2012 has been quite a year for the business, we were named as one of The Sunday Times 100 Best Companies to Work For, becoming the first veterinary group to be awarded this accolade. Our growth has been such that we have recently launched a dedicated recruitment website, we have employed our 1,000th team member and to be opening our 100th surgery is testament to the hard work and dedication of our fantastic team."
Companion Care now has 117 Joint Veterinary Partners, 96 of whom are veterinary surgeons, 13 veterinary nurses, 7 practice managers and a receptionist and a further 953 colleagues employed by the group. The company says it has doubled in size in the past three years and is on track to do so again by 2015.
Jane said: "At present the majority of our surgeries are part of the Pets at Home in-store model but there are already five very successful standalone surgeries and the standalone surgery network plan is being developed to cater for those vets and veterinary nurses whose preference is to have a more traditional standalone surgery."
Rhian said: "A local girl, I have just moved back to Llantrisant and am really excited to be running my own practice in an area that I love. I set myself very high clinical standards and always involve the client in treatment and their pet's wellbeing. There is nothing that satisfies me more than well animals and happy clients."
Rhian and her team are involving the local community in the opening and will have guests from local branches of the Dogs Trust and the Cats Protection League present on opening day raising funds and joining in the celebrations.
ECC vet Shailen Jasani has launched a crowdfunding campaign to raise funds for further development of his pet bereavement website, www.theralphsite.com
The Ralph Site is a non-profit pet bereavement support online resource and Facebook community which Shailen set up in 2011 after the loss of his cat Ralph.
Shailen says that over the past three years, the site has proved to be a much needed resource, with many pet carers benefiting from what it offers and a growing number of practices referring their bereaved clients to the site for information and support, and a sympathetic and empathetic virtual ear. So far, the site has had approximately 60,000 visitors and the Facebook community now stands at an impressive 34,000 Likes.
Shailen manages the site by himself and has has also personally funded all of the expenses to date including design, development, on-going management and promotion costs, to the tune of £30,000.
However, he says he now needs further funds to make the site work properly on smartphones and tablets, improve the memorial section and promote it more widely to pet owners, for which he is turning to crowdfunding and hoping that members of the profession will support what he is doing, both with contributions and by helping spread the word amongst family, colleagues and clients.
Shailen said: "The issue of pet bereavement and the impact of pet loss on their carers is a serious one which is slowly but surely gaining increasing recognition. A resource such as the Ralph Site is invaluable for practices to be able to link and refer clients to. I very much hope colleagues will get behind my campaign."
To find out more about the campaign, visit: http://igg.me/at/theralphsite/x
Norbrook has launched Loxicom 0.5mg/ml oral suspension for small dogs, indicated for the alleviation of inflammation and pain in acute and chronic musculo-skeletal disorders.
Loxicom Oral Suspension comes in a clear 15ml bottle which allows vets and clients to monitor levels of the product and re-order when necessary.
Loxicom 0.5mg/ml for Dogs comes with two sizes of syringe, a 1ml syringe graduated from 0.25kg-5kg to treat even the smallest of dog breeds accurately, and a 5ml syringe graduated from 1kg-25kg to treat small and medium dog breeds. The syringes plug securely into the bottle to ensure a tight-fitting connection and minimal leakage when administering the product.
This new oral suspension joins the range of 1.5mg/ml oral suspensions for Dogs and 5mg/ml injections for Dogs and Cats, launched in 2009, and the 0.5mg/ml oral suspension for Cats launched earlier this year at the BSAVA Congress.
Those who pay their fees after 30 April 2017 will be charged an extra £35 to renew their registration while those who have not paid by 31 May 2017 will be removed from the Register.
You will also need to confirm your registration details, confirm you've met the RCVS requirement for continuing professional development of 105 hours over a three-year rolling period and disclose any new or previously undisclosed convictions, cautions or adverse findings.
The annual renewal can be completed by logging into the ‘My Account’ area of the RCVS website (www.rcvs.org.uk/login). For those members who do not have a valid email address, or have requested a hard copy of the renewal form, a form has been sent by post.
Any veterinary surgeons who have not received their annual renewal form or security details for the ‘My Account’ area by 7 March should contact the RCVS Registration Department on 020 7202 0707 or registration@rcvs.org.uk as soon as possible.
Those with queries about paying the annual renewal fee should contact the RCVS Finance Team on 020 7202 0723 or finance@rcvs.org.uk
Carried out by the Royal Veterinary College (RVC), the Animal Health Trust (AHT) and Rossdales Equine Hospital, the study also revealed that the groups particularly at risk were native pony breeds and their crosses, as well as horses and ponies with a history of laminitis and those with lameness or soreness after routine hoof care.
This research, funded by World Horse Welfare, comes from the first ever online study that collected information on laminitis from a group of owners in real time.
The researchers say that the study is also the second largest to identify weight gain as a risk factor for laminitis. Data was collected from the owners of 1,070 horses and ponies in Great Britain, who reported their animal’s management, health and estimated weight via online questionnaires for 29 months.
Owners were encouraged to use a custom weight tracking tool designed by the study/research team to help regularly track changes in their animal’s weight and body condition. The uptake of this tool was high, with over half of participating owners using it.
The tool is freely available at: www.aht.org.uk/research/lameness/laminitis.
Other study findings included:
A high risk of laminitis was present in horses shod or trimmed at intervals of more than 8 weeks, and in those that took a long time to return to soundness after a bout of laminitis.
Diet, grazing management and health were factors closely associated with the development of laminitis and will be the subject of future investigation.
Researchers also noted that weight gain often occurred unintentionally, even when owners were aiming for their animals to maintain or lose it. This reiterates the need to consistently record weight and body condition in order to prevent undesirable weight gain.
Dr. Dee Pollard of the AHT, one of the study’s chief authors, said: "This is one of the largest, and the first, online laminitis studies where we collected regular information from the same group of owners in real-time. We assessed the relationship between laminitis and many potential management and health factors and identified those more likely to be present before a laminitis episode was reported.
"We now have good evidence to develop laminitis prevention guidelines, and a number of different avenues to explore in the future. We cannot emphasise enough how important systematic and regular weight and body condition monitoring are. It’s very easy to miss weight gain when you are just relying on your eyes and you see your horse or pony every day. You need to get hands on, feel for the fat deposits and take measurements, remember the figures don’t lie!"
Reference
As part of its review, the College had planned a series of focus groups of veterinary surgeons and nurses across the UK. However, these have had to be delayed both because of social distancing rules and because of the pressures that practice teams are currently working under. However, the agency tasked with hosting the focus groups is now exploring alternative options and it is hoped there will be a revised timetable soon.
In the meantime, the College says it now plans to commission an additional independent agency to survey veterinary surgeons about their experience of remote prescribing during lockdown.
In March, RCVS Council agreed to temporarily allow veterinary surgeons to prescribe prescription-only veterinary medicines remotely, without first having physically examined the animal, subject to a number of conditions and safeguards being in place.
This position is due for review by 30th June, and the College will be looking for feedback and data from veterinary surgeons about your experience of remote prescribing, in order to determine whether these arrangements can continue, with or without any extra safeguards.
Because remote prescribing is also one of the most important aspects of the planned under care review, feedback gathered now will help inform future discussions too.
RCVS President Niall Connell said: “We recognise the current conditions that veterinary practices are working under in no way represent normal practice life. Most practices will not have been set up to offer remote services and remote prescribing in a way that they might have chosen, given sufficient time and appropriate detailed guidance, if indeed there are any future guidance changes after the review.
"However, we feel it would be remiss of us not to seize the opportunity arising from this current crisis to ask about the experiences – good or bad – of those on the frontline of clinical veterinary practice in providing remote services to their clients.
"Whilst this will be no substitute for the formal evidence gathered by the research agency in due course, whatever data and feedback we can collate from veterinary practices at this unique time for our professions will, I’m sure, be extremely valuable to our ongoing discussions."
BlueSky says that conventional treatment for equine sarcoids, which are induced by tumour antigens E6 and E7 of the bovine papillomavirus, have only limited effect and typically result in the recurrence of the tumours.
However, research published by the company in PLoSONE1 showed that sarcoids treated with delNS/E6E7 were completely and permanently eliminated.
For the study, 29 horses were treated with different regimes involving direct injection into the tumours over three years.
Visible and very significant regression of the sarcoids was achieved in 20 of the treated horses, and 100% regression of the sarcoids in 10 equine patients.
Thomas Muster, CEO of BlueSky Immunotherapies said: "The complete elimination of very aggressive and difficult-to-cure equine sarcoids is yet another important proof of the potential offered by our delNS platform."
In addition, the systemic delNS-mediated immune stimulation eliminated non-injected sarcoids and the papillomavirus that caused the sarcoids.
Thomas added: "We are therefore confident that we will also be able to successfully heal and/or eliminate the cervical tumours of the women enrolled in the clinical trials currently under way."
The University of Liverpool's School of Veterinary Science has released the results of research carried out in collaboration with the Royal Canin Research Centre in France, which shows that cats eat 15% less in the summer than the winter.
Researchers spent four years monitoring how much cats chose to eat. The 38 cats studied had a microchip on their collar which allowed them to take as much food as they wanted from a dispenser which only opened for them. At the same time, this microchip recorded how much the cat had eaten and when.
Veterinary surgeon and study author, Dr Alex German, said: "Cats, like many humans are more inclined to comfort eat when it's cold outside but, in their case, it's likely to be due to the extra energy they need to keep warm when out and about."
The study found that cats ate approximately 15% less food during summer, and the researchers concluded that the extra effort to keep warm in winter and the temptation to rest during hot summer days contributed to the swing in activity levels during the year.
The cats were all inhabitants of a centre in southern France where they were allowed to play and exercise outside all year round. The cats were of mixed breeds, ages and genders. Data on food was compared to the climate in the area using computer modelling to provide information about how the temperature changed over the year.
Seasonal food intake has also been examined in the past on farm animals, such as dairy cows, to establish new ways of increasing milk production, but this is the largest study that has yet taken place with domestic cats.
Dr German said: "People should consider the amount of food their cats need at different times of year as this can be part of helping them to maintain a healthy weight."
The paper was published in the journal PLOS One. http://dx.plos.org/10.1371/journal.pone.0096071
Genitrix has launched Dentagen, billed as the UK’s first dental plaque protection system for dogs and cats.
The active principle in Dentagen is a plant extract called RF2 and the product operates as an ‘anti-biofilm’ treatment by modifying the membrane of oral bacteria to prevent them from producing plaque even at low concentrations.
Dentagen wax is presented for practice use in a syringe for easy application to the gingival layer and the buccal area of teeth. The initial protective coating of wax is applied to dogs or cats at end of dental procedures in practice and while the animal is still sedated. The coating lasts for two to three days.
Dog owners can then maintain the protective coating by giving their pet Dentagen plaque prevention chews every other day. The chews, impregnated with RF2 and of a specially designed shape and consistency, are supplied in two sizes with the larger size designed for dogs over 8 kg and a smaller size for dogs less than 8 kg.
Vet Katy Horton of White Hart Lane Vets, who has trialled the product, commented: “The Dentagen wax was certainly very easy to apply and, from the small sample of dogs we’ve so far tried it on, the palatability of the chews was good. While tooth-brushing remains the gold standard for dental care, we recognise that it can be difficult for owners and believe that this new approach could be a valuable alternative.”
Five syringes of Dentagen for application in practice cost £12.50. Packs of nine small chews cost £5.10 while a pack of the larger chews costs £6.50.
New research from the USA, published in the Equine Veterinary Journal (EVJ), has shown that a toxin from the box elder tree is the likely cause of Seasonal Pasture Myopathy (SPM), the US equivalent of the European disease known as Atypical Myopathy (AM).
According to the British Equine Veterinary Association, preliminary comparisons of these results with cases of AM in Europe suggest that the European condition may be linked to similar trees which could have an important bearing on the future prevention of the disease in Europe.
Seasonal Pasture Myopathy is a highly fatal muscle disease in Midwestern USA and Eastern Canada. A similar disorder called Atypical Myopathy is becoming increasingly frequent in the UK and Northern Europe. Outbreaks of both diseases tend to be seasonal, with most cases occurring in the autumn. Horses that develop SPM and AM are usually kept in sparse pastures with an accumulation of dead leaves dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed.
The research1 identified that seeds from box elder trees were consistently present in the autumn pastures of all 12 horses enrolled in the study. These horses were from 11 different farms and had all presented with the clinical signs of SPM, which include muscular weakness and stiffness, dark urine, periods of recumbency, colic-like signs and muscle trembling. The toxic amino acid hypoglycin A, which is known to cause acquired multiple acyl CoA dehydrogenase deficiency (MADD) was shown to be present in the box elder seeds and hypoglycin metabolites were identified in the serum or urine of all the horses. All but one of the cases proved fatal.
Professor Valberg DVM PhD of the Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, who instigated the study, said: "The fact that another acquired form of MADD in rats and humans is caused by hypoglycin A ingestion strengthens our conclusion that hypoglycin A is the likely toxic cause of SPM in horses. We are intending to conduct further studies to determine the factors that affect the highly variable hypoglycin A concentrations in box elder seeds."
Professor Valberg has established collaborative links with groups in Europe in order to investigate if a similar toxin is involved in European Atypical Myopathy. Working with Professor Vince Gerber and Dr Lucia Unger at the University of Bern, Professor Valberg has obtained seeds from a tree related to the Box Elder found on many pastures where Atypical Myopathy has occurred.
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is a really important step forwards. We don't yet know for sure that the cause of European disease, Atypical Myopathy, is the same as Seasonal Pasture Myopathy in the US. But the clinical signs and MADD aberrations are identical and both conditions have a high fatality rate. It remains to be seen whether this research will help European horses, but there is no doubt that it will allow American horse owners to prevent this devastating condition affecting their horses with immediate effect."
1 Seasonal Pasture Myopathy/Atypical Myopathy in North America associated with Ingestion of Hypoglycin A within Seeds of the Box Elder Tree Stephanie J Valberg DVM PhD1, Beatrice T Sponseller Dr. med. vet2, Adrian D Hegeman PhD3, Jennifer Earing PhD, Jeffery B. Bender DVM MS1, Krishona L Martinson PhD4, Steven E Patterson PhD5, Lawrence Sweetman PhD1
Animal Health and Veterinary Laboratories Agency (AHVLA) has announced the formation of a new independent advisory group to recommend a future delivery model for veterinary surveillance in England and Wales.
The Advisory Group will be chaired by Dirk Pfeiffer, Professor of Veterinary Epidemiology at the Royal Veterinary College. According to the AHVLA, it will include representatives from government, the veterinary profession and the livestock farming and private laboratory industries and is being created so all those with an interest in veterinary surveillance can shape a future model and ensure that all issues are thoroughly considered.
Veterinary surveillance seeks to identify new or re-emerging threats to our livestock population and to public health. It involves a partnership approach between livestock keepers, private veterinary surgeons, the Scottish Agricultural College, industry bodies and AHVLA in order to effectively gather and assess intelligence.
AHVLA is seeking to identify ways to undertake veterinary surveillance both more effectively and at an affordable cost to the taxpayer. Work in this area has been on-going since 2010, and the merger of the former Animal Health and Veterinary Laboratories Agency (VLA) has created opportunities to review how veterinary surveillance can best be delivered.
The new model will aim to address capacity imbalances in the current service where provision sometimes outstrips demand. The independent advisory group are also expected to recommend how better and closer working methods across the partners can make the surveillance stronger as well as more cost effective.
Surveillance has historically been based on in-depth investigation of disease incidents with an emphasis on post mortem examinations carried out at AHVLA's regional laboratories. This system is a key element in the government's risk-based approach to the management of animal disease related threats.
AHVLA says that the current model, although successful in identifying diseases in the past, can be improved upon. A recent internal AHVLA report identified viable options for achieving better surveillance at the same or lower cost by, for example, exploring moving towards risk and intelligence based surveillance and improving the value added by working more closely in partnership with vets and their farmer clients and other sources of intelligence data.
In mid-January 2012, AHVLA will also be publishing, and publicising, an online survey aimed at individual veterinary practioners and livestock keepers. The survey will seek individual opinions on the inputs, mechanisms, outputs and value of surveillance in England and Wales Work is expected to run until spring 2012, following which recommendations on a way forward will be made.
Carl Padgett, President of the BVA, said: “Veterinary surveillance is an essential component in our animal health, public health, food security, and international trade work.
“The emergence of Schmallenberg virus in ruminants in northern Europe demonstrates the current value and ongoing need for a robust surveillance system to work both nationally and internationally.
“The BVA welcomes the establishment of the advisory group and particularly the wide range of veterinary expertise and experience that is represented on the group. It is important that views from both veterinary practitioners and veterinary scientists are fed into this review.
“While we understand that AHVLA and Defra must ensure value for money from the surveillance network, any future model must be shaped by good surveillance strategies, not the need to cut costs.
“We urge all practitioners in England and Wales to contribute to the discussions by completing the online survey.
“We look forward to engaging with the advisory group as it carries out the review and beyond.”
The RCVS has announced that the Code of Professional Conduct has been updated to restrict - from April 2016 - the use of the word specialist and its derivatives in veterinary practice marketing and promotional materials, except when referring to an RCVS Recognised Specialist.
Alternatives for practitioners who want to describe a special area of expertise in their marketing materials, but who are not on the RCVS list of Specialists include: 'Special interest in ...', 'Experienced in ...', 'Advanced qualifications in ...', or, for those who hold the status, 'Advanced Practitioner'.
The College says the changes will also apply to European Veterinary Specialists fully recognised by the European Board of Veterinary Specialisation, who will now need to join the RCVS list if they wish to use the title in the UK. However, European Specialists will be offered a simplified application process and a 50% reduction in the fee, because their revalidation is carried out by their specialist European college.
The College has also extended the deadline for new applications for Specialist Status to 30th September 2015. The deadline for re-applications by existing RCVS Specialists remains 14th August 2015.
In addition to changing the Code, the College has also amended Chapter 23 of its supporting guidance ('Advertising and publicity') to give more detailed advice on use of the terms 'specialist' and 'specialising in' in the context of advertising and referrals.
Gordon Hockey, RCVS Registrar, said: "Specialist status is not easy to achieve. Those who hold it have achieved a postgraduate qualification at a minimum of Diploma level and have satisfied us that they make an active contribution in their speciality, for example, through publishing academic papers.
"The change to the Code of Professional Conduct is therefore intended to ensure the integrity of the specialist list and title, so that those who do not have RCVS-recognised qualifications, experience and expertise do not claim or imply they hold such a status.
"These changes will benefit the public and, ultimately, animal welfare by clearly identifying those who have specialised knowledge and skills. They should also aid members of the broader profession in the UK when they are deciding who they should refer cases to.
"We recognise this represents a significant change which is why we have allowed a 'bedding in' period before the change comes into force, as well as extending the deadline for applications."
To find out more about applying for Specialist status, visit www.rcvs.org.uk/specialists. The List of RCVS Specialists is available at www.rcvs.org.uk/listofspecialists. Details of the updates made to the Code can be found at www.rcvs.org.uk/vetcode. These changes have also been reflected in the RCVS Code of Professional Conduct app which can be downloaded from www.rcvs.org.uk/codeapp.
Following the launch of Libromide, the only licensed formulation of potassium bromide in the UK for canine epilepsy, Genitrix has linked up with NationWide Veterinary Laboratories to offer a discounted blood test service to veterinary practices.
Genitrix says it is offering the discounted blood tests to help practices and encourage owners to test regularly, thus ensuring that the level of Libromide in dogs undergoing treatment remains within the recommended therapeutic range.
According to the company, factors which can cause the level to move out of therapeutic range include an increase in the chloride content of the diet or the administration of other drugs. Because Libromide takes a few weeks to reach a steady therapeutic state, testing at four, eight and twelve weeks is also recommended at the commencement of treatment to confirm that the rise to therapeutic level takes place.
To take advantage of the discount scheme, practices can download a test form from the Genitrix website (http://www.genitrix.co.uk/) or call its head office on 01403 786345. Copies are also available from wholesalers.
Rob Watkins, Marketing Director at Genitrix, said: "Regular blood testing of epileptic dogs is an essential element of a successful treatment regime and is recommended by all canine epilepsy specialists. Unfortunately, feedback from practices suggests that owners are sometimes reluctant to comply with this advice and that the cost of testing is frequently an issue.
"We've launched the scheme to help practices increase compliance by making it significantly cheaper. Taking advantage of this scheme for blood testing is also convenient for practices now that the test forms can be downloaded as well as ordered by phone.
"Recent data suggests that canine epilepsy affects four in every hundred dogs making it a common disease affecting dogs in the UK. Following on from the launch of Libromide, we hope that the discounted blood test scheme will be another step forward in the move to improve treatment approaches for this distressing disease."